Mouse Anti-E2F1 Recombinant Antibody (VS3-FY2693) (CAT#: VS3-FY2693)

The anti-E2F1 antibody is specifically engineered to target human E2F1 protein. It shows capability of cross-reacting with mouse and rat. This monoclonal antibody proves valuable in disease research related to Retinoblastoma and Squamous Cell Carcinoma.

Specific Inquiry
  • Size:
  • Conjugation:
  • Endotoxin:
  • Purity:
  • Formats:
  • Isotype Switching:
  • Fc Engineering:
  • Modalities:
  • Gene Expression
  • Datasheet
  • MSDS
  • COA
Subcellular Location
Normal Tissue
RNA Expression

Specifications

  • Host Species
  • Mouse
  • Type
  • Mouse IgG
  • Specificity
  • E2F transcription factor 1 of human, mouse and rat origins
  • Species Reactivity
  • Human, Mouse, Rat
  • Applications
  • WB, ICC, IP
  • Conjugate
  • Unconjugated, FITC
  • Related Disease
  • Retinoblastoma and Squamous Cell Carcinoma

Product Property

  • Clonality
  • Monoclonal Antibody
  • Format
  • Liquid
  • Concentration
  • Please refer to the vial label for the specific concentration.
  • Storage
  • Centrifuge briefly prior to opening vial. Store at +4°C for short term (1-2 weeks). Aliquot and store at -20°C for long term. Avoid repeated freeze/thaw cycles.

Applications

  • Application Notes
  • Immunoprecipitation: 1/20
    Western Blot: 1/500-1/1000
    Immunocytochemistry: 1/50-1/200

Target

  • Alternative Names
  • E2F1; RBBP3; Transcription factor E2F1; E2F-1; PBR3; Retinoblastoma-associated protein 1; RBAP-1; Retinoblastoma-binding protein 3; RBBP-3; pRB-binding protein E2F-1
  • Sequence Similarities
  • Belongs to the E2F/DP family.
  • Cellular Localization
  • Nucleus
  • Post Translation Modifications
  • Phosphorylated by CDK2 and cyclin A-CDK2 in the S-phase
    Ubiquitinated via 'Lys-63'-linked ubiquitin, leading to its degradation
    Acetylation stimulates DNA-binding.
    Methylation at Lys-185 by SETD7 promotes E2F1 ubiquitin-dependent proteasomal degradation.
    Modification sites at PhosphoSitePlus
    Modification sites at neXtProt
  • Function
  • The DRTF1/E2F complex functions in the control of cell-cycle progression from G1 to S phase (PubMed:10675335, 12717439, 17704056).
    E2F1 binds preferentially RB1 in a cell-cycle dependent manner (PubMed:10675335, 12717439, 17704056).
    It can mediate both cell proliferation and TP53/p53-dependent apoptosis (PubMed:8170954).
    Blocks adipocyte differentiation by binding to specific promoters repressing CEBPA binding to its target gene promoters.

Recommended Products

Related Resources

  • Related Diseases

Product Notes

This is a product of Creative Biolabs' Hi-Affi™ recombinant antibody portfolio, which has several benefits including:

• Increased sensitivity
• Confirmed specificity
• High repeatability
• Excellent batch-to-batch consistency
• Sustainable supply
• Animal-free production

See more details about Hi-Affi™ recombinant antibody benefits.

Downloads

Download resources about recombinant antibody development and antibody engineering to boost your research.

See other products for "E2F1"

Select a product category from the dropdown menu below to view related products.
Please select product type
IgG Antibody Products Rabbit Monoclonal Antibody Products

Customer Reviews and Q&As

Submit a review or a question

There are currently no Customer reviews or questions for VS3-FY2693. Click the button above to contact us or submit your feedback about this product.

Popular products with customers


For Research Use Only. Not For Clinical Use.

For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.

Send Inquiry

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

  • 0
  • 0
Cart
    Go to compare

    Go to compare